Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus without established cardiovascular disease: Do they have a role in primary prevention?

Most guidelines and cardiovascular outcome trials (CVOTs) focus on secondary prevention of cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM). Patients with T2DM without established CVD (eCVD) also form a critical cohort, for whom primary prevention with timely pharmacological and non-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kale, Shailaja, Tahrani, Abd A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010211/
https://www.ncbi.nlm.nih.gov/pubmed/33817616
http://dx.doi.org/10.1016/j.metop.2021.100082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010211/
https://www.ncbi.nlm.nih.gov/pubmed/33817616
http://dx.doi.org/10.1016/j.metop.2021.100082

Ejemplares similares